Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
Withdrawn before enrolling · Not applicable · Has a placebo group
Conditions studied: Huntington's Disease, Parkinson's Disease, Dementia With Lewy Bodies, Sleep Disorders, Circadian Dysregulation
In brief
The proposed study is a double-blind, placebo controlled pilot study of HD, PD, and DLB subjects with sleep disturbances. This study is designed to determine the effects of 4 weeks Ramelteon treatment on the sleep patterns of people with basal ganglia disorders such as HD, PD and DLB. The study also aims to look at the sleep patterns of caregivers of people with HD, PD and DLB.
Key facts
- Study ID
- NCT00907595
- Run by
- Massachusetts General Hospital
- People needed
- 0
- Starts
- 2009-05-01
- Expected to finish
- 2010-07-01
- Last updated by the study team
- 2012-11-06
Who can join
Age: 20 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.